Alpha Teknova profit margin TKNO
Gross, operating and net profit as a share of revenue over the last twelve months, from 2020.
- Net margin, 12 months
- −38.4%
- Operating margin, 12 months
- −36.2%
- Net margin on a year earlier
- +16.9 pts
- Peer median
- 6.5%
Over the twelve months to Jun 30, 2026, Alpha Teknova kept −38.4% of its revenue as net profit, with an operating margin of −36.2% and a gross margin of 34.6%.
Five years earlier its net margin was −2.2%.
The median for 10 healthcare stocks of a similar size is 6.5%.
Profit margin over time
Fiscal year by fiscal year
| Fiscal year | Net margin | Operating margin | Gross margin |
|---|---|---|---|
| FY2025 | −42.6% | −41.9% | 33.2% |
| FY2024 | −70.9% | −69.3% | 19.2% |
| FY2023 | n/a | −96.9% | 28.1% |
| FY2022 | n/a | n/a | 42.2% |
| FY2021 | −26.6% | −32.6% | 47.8% |
| FY2020 | 11.4% | 14.9% | 56.7% |
Quarter by quarter
| Quarter | Ended | Net margin, 12 months | Change on a year | Operating margin |
|---|---|---|---|---|
| Q2 FY26 | −38.4% | +16.9 pts | −36.2% | |
| Q1 FY26 | −41.1% | +19.8 pts | −39.0% | |
| Q4 FY25 | −42.6% | +28.3 pts | −41.9% | |
| Q3 FY25 | −45.8% | +41.4 pts | −45.2% | |
| Q2 FY25 | −55.2% | +42.8 pts | −55.0% | |
| Q1 FY25 | −60.9% | +37.0 pts | −60.5% | |
| Q4 FY24 | −70.9% | n/a | −69.3% | |
| Q3 FY24 | −87.2% | n/a | −86.3% | |
| Q2 FY24 | −98.1% | n/a | −93.6% | |
| Q1 FY24 | −97.8% | n/a | −93.9% | |
| Q4 FY23 | n/a | n/a | −96.9% | |
| Q3 FY23 | n/a | n/a | n/a |
Against its peers
Companies in Healthcare nearest Alpha Teknova's size, closest first, today.
| Company | Profit margin |
|---|---|
| TKNOAlpha Teknova | −38.4% |
| VMDViemed Healthcare | 4.8% |
| EMBCEmbecta | 8.6% |
| INFUInfuSystem | 6.0% |
| ARVNArvinas | 2.9% |
| NRCNRC Health | 4.2% |
| UTMDUtah Medical Products | 29.0% |
| TCMDTactile Systems Technology | 7.1% |
| ELMDElectromed | 15.3% |
| SBCSBC Medical | 28.0% |
| NATRNatures Sunshine Products | 3.7% |
| Peer median | 6.5% |
What the profit margin tells you
Profit as a share of revenue at three levels: gross (after making the product), operating (after running the business) and net (after everything, including tax and interest).
Compare within an industry. 10% is superb for a retailer and poor for a software company.
More on Alpha Teknova
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.